Trial Profile
VITAL-DEP: Depression Endpoint Prevention in the VITamin D and OmegA-3 TriaL
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 16 Mar 2023
Price :
$35
*
At a glance
- Drugs Colecalciferol (Primary) ; Omega-3-acid ethyl esters (Primary)
- Indications Major depressive disorder
- Focus Therapeutic Use
- Acronyms VITAL-DEP
- 12 Dec 2021 Primary endpoint has not been met (Mood scores) as per results published in the JAMA: the Journal of the American Medical Association
- 12 Dec 2021 Primary endpoint has not been met (Depression) as per results published in the JAMA: the Journal of the American Medical Association
- 12 Dec 2021 Results published in the JAMA: the Journal of the American Medical Association